There are no large-scale, randomized, double-blind, placebo-controlled human clinical trials of BPC-157, TB-500, or GHK-Cu specifically for herniated disc repair
However, due to the insufficiency of clinical evidence, it cannot be used as a first-line treatment drug at present
A non-GLP-1 alternative with different side effect profiles
The effectiveness duration of vitamin B12 depends on multiple elements, as per your inquiries about its operational period
Structural modifications, such as attaching a lipid chain to a lysine residue, can enhance the peptides effectiveness by prolonging its half-life and bioavailability through non-covalent interactions with albumin